The perforin-dependent immunological synapse allows T-cell activation-dependent tumor targeting by MLV vector particles (original) (raw)

• Pizzato M, Marlow SA, Blair ED, Takeuchi Y . Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction. J Virol 1999; 73: 8599–8611.
  CAS PubMed PubMed Central Google Scholar
• Pizzato M, Blair ED, Fling M, Kopf J, Tomassetti A, Weiss RA et al. Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells. Gene Therapy 2001; 8: 1088–1096.
  Article CAS PubMed Google Scholar
• Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000; 100: 587–597.
  Article CAS PubMed Google Scholar
• Bobardt MD, Saphire AC, Hung HC, Yu X, Van der Schueren B, Zhang Z et al. Syndecan captures, protects, and transmits HIV to T lymphocytes. Immunity 2003; 18: 27–39.
  Article CAS PubMed Google Scholar
• Blomer U, Gruh I, Witschel H, Haverich A, Martin U . Shuttle of lentiviral vectors via transplanted cells in vivo. Gene Therapy 2005; 12: 67–74.
  Article CAS PubMed Google Scholar
• Harrington KJ, Alvarez-Vallina L, Crittenden M, Gough M, Chong H, Diaz RM et al. Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery. Hum Gene Ther 2002; 13: 1263–1280.
  Article CAS PubMed Google Scholar
• Chester J, Ruchatz A, Gough M, Crittenden M, Chong H, Loic-Cosset F et al. Tumor antigen-specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor-modified T cells. Nat Biotechnol 2002; 20: 256–263.
  Article CAS PubMed Google Scholar
• Crittenden M, Gough M, Chester J, Kottke T, Thompson J, Ruchatz A et al. Pharmacologically regulated production of targeted retrovirus from T cells for systemic anti-tumor gene therapy. Cancer Res 2003; 63: 3178–3180.
  Google Scholar
• Harrington KJ, Linardakis E, Vile RG . Transcriptional control: an essential component of cancer gene therapy strategies? Adv Drug Delivery Rev 2000; 44: 167–184.
  Article CAS Google Scholar
• Cole C, Qiao J, Kottke T, Diaz RM, Sanchez-Perez L, Blum G et al. Systemic delivery of therapeutic viral vectors using hitch hiking on antigen specific T cells. Nat Med 2005; 11: 1073–1081.
  Article CAS PubMed Google Scholar
• Rosenberg SA, Dudley ME . Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes. Proc Natl Acad Sci USA 2004; 101 (Suppl 2): 14639–14645.
  Article CAS PubMed PubMed Central Google Scholar
• Dudley ME, Rosenberg SA . Adoptive-Cell-Transfer therapy for the treatment of patients with cancer. Nat Rev Cancer 2003; 3: 666–676.
  Article CAS PubMed PubMed Central Google Scholar
• Yee C, Riddell SR, Greenberg PD . In vivo tracking of tumor-specific T cells. Curr Opin Immunol 2001; 13: 141–146.
  Article CAS PubMed Google Scholar
• Yee C, Thompson JA, Roche P, Byrd DR, Lee PP, Piepkorn M et al. Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of T cell-mediated vitiligo. J Exp Med 2000; 192: 1637–1644.
  Article CAS PubMed PubMed Central Google Scholar
• Dudley ME, Wunderlich J, Nishimura MI, Yu D, Yang JC, Topalian SL et al. Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma. J Immunother 2001; 24: 363–373.
  Article CAS PubMed Google Scholar
• Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 2002; 298: 850–854.
  Article CAS PubMed PubMed Central Google Scholar
• Palmer D, Balasubramaniam S, Hanada K, Wrzesinski C, Yu Z, Farid S et al. Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destruction. J Immunol 2004; 15: 7209–7216.
  Article Google Scholar
• Hogquist KA, Jameson SC, Health WR, Howard JL, Bevan MJ, Carbone FR . T cell receptor antagonistic peptides induce positive selection. Cell 1994; 76: 17.
  Article CAS PubMed Google Scholar
• Liebermann J . The ABCs of granule-mediated cytotoxicity: new weapons in the Arsenal. Nat Rev Immunol 2003; 3: 361–370.
  Article Google Scholar
• Bots M, Kolfscoten IGM, Bres S, Rademaker MTGA, de Roo GM, Kruse M et al. SPI-CI and SPI-6 cooperate in the protection from effector cell-mediated cytotoxicity. Blood 2005; 105: 1153–1161.
  Article CAS PubMed Google Scholar
• Froelich CJ, Orth K, Turbov J, Seth P, Gottlieb R, Babior B et al. New paradigm for lymphocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis. J Biol Chem 1996; 271: 29073–29079.
  Article CAS PubMed Google Scholar
• Browne KA, Blink E, Sutton VR, Froelich CJ, Jans DA, Trapani JA . Cytosolic delivery of granzyme B by bacterial toxins: evidence that endosomal disruption, in addition to transmembrane pore formation, is an important function of perforin. Mol Cell Biol 1999; 19: 8604–8615.
  Article CAS PubMed PubMed Central Google Scholar
• Kurschus FC, Bruno R, Fellows E, Falk CS, Jenne DE . Membrane receptors are not required to deliver granzyme B during killer cell attack. Blood 2005; 105: 2049–2058.
  Article CAS PubMed Google Scholar
• Raja SM, Metkar SS, Froelich CJ . Cytotoxic granule-mediated apoptosis: unraveling the complex mechanism. Curr Opin Immunol 2003; 15: 528–532.
  Article CAS PubMed Google Scholar
• Igakura T, Stinchcombe JC, Goon PK, Taylor GP, Weber JN, Griffiths GM et al. Spread of HTLV-I between lymphocytes by virus induced polarisation of the cytoskeleton. Science 2003; 299: 1670–1671.
  Article Google Scholar
• Jolly C, Kashefi K, Hollinshead M, Sattentau QJ . HIV-1 cell transfer across an env-induced, actin dependent synapse. J Exp Med 2004; 19: 283–293.
  Article Google Scholar
• Sandrin V, Russell SJ, Cosset FL . Targeting retroviral and lentiviral vectors. Curr Top Microbiol and Immunol 2003; 281: 137–178.
  CAS Google Scholar
• Weiss RA, Chetankuma ST . Retrovirus receptors. Cell 1995; 82: 531–533.
  Article CAS PubMed Google Scholar
• Linardakis E, Bateman A, Phan V, Ahmed A, Gough M, Olivier K et al. Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion. Cancer Res 2002; 62: 5495–5504.
  CAS PubMed Google Scholar
• Miller AD, Garcia JV, Von Suhr N, Lynch CM, Wilson C, Eiden MV . Construction and properties of retroviral packaging cells based on gibbon ape leukemia virus. J Virol 1991; 65: 2220–2224.
  CAS PubMed PubMed Central Google Scholar
• Grossman WJ, Verbsky JW, Tollefsen BL, Kemper C, Atkinson JP, Ley TJ . Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 2004; 104: 2840–2848.
  Article CAS PubMed Google Scholar
• Kolokoltsov AA, Davey RA . Rapid and sensitive detection of retrovirus entry by using a novel luciferase-based content mixing assay. J Virol 2004; 78: 5124–5132.
  Article CAS PubMed PubMed Central Google Scholar
• Wagner RR, Rose JK In: Fields BN, Knupe DM, Howley PM (eds). Fundamental Virology. Lippincott-Raven Publishers: Philadelphia, 1996, pp 561–575.
  Google Scholar
• Chong H, Todryk S, Hutchinson G, Hart IR, Vile RG . Tumour cell expression of B7 costimulatory molecules and interleukin-12 or granulocyte–macrophage colony stimulating factor induces a local antitumour response and may generate systemic protective immunity. Gene Therapy 1998; 5: 223–232.
  Article CAS PubMed Google Scholar
• Morgenstern JP, Land H . Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 1990; 18: 3587–3596.
  Article CAS PubMed PubMed Central Google Scholar
• Diaz RM, Eisen T, Hart IR, Vile RG . Exchange of viral promoter/enhancer elements with heterologous regulatory sequences generates targeted hybrid long terminal repeat vectors for gene therapy of melanoma. J Virol 1998; 72: 789–795.
  CAS PubMed PubMed Central Google Scholar
• Wagner MJ, Sharp JA, Summers WC . Nucleotide sequence of the thymidine kinase gene of herpes simplex virus type 1. Proc Natl Acad Sci USA 1981; 78: 1441–1445.
  Article CAS PubMed PubMed Central Google Scholar
• Markowitz D, Goff S, Bank A . Construction and use of a safe and efficient amphotropic packaging cell line. Virology 1988; 167: 400–406.
  Article CAS PubMed Google Scholar
• Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK . Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 1993; 90: 8033–8037.
  Article CAS PubMed PubMed Central Google Scholar
• Daniels G, Sanchez-Perez L, Kottke T, Diaz RM, Thompson J, Lai M et al. A simple method to cure established tumors by inflammatory killing of normal cells. Nat Biotechnol 2004; 22: 1125–1132.
  Article CAS PubMed Google Scholar
• Altman DG (ed). Analysis of survival times. In Practical Statistics for Medical Research. London: Chapman and Hall, 1991, pp 365–395.
  Google Scholar